Follow The Filings

OFLX

Earnings company data as of 9:00 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by OFLX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OFLX insider trades
  • $207K bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Edwin B. Moran President
    Buy
    $20K 790 shares at $25.43 +79% to stake
    Traded Sep 14 Filed Sep 14
  2. Matthew Francis Unger CFO
    Buy
    $25K 1,000 shares at $25.42 New stake
    Traded Sep 14 Filed Sep 14
  3. Dean W. Rivest CEO
    Buy
    $30K 1,000 shares at $29.50 New stake
    Traded Mar 11 Filed Mar 13
  4. David K Evans Director
    Buy
    $12K 384 shares at $30.64 +38% to stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
  5. Stephen M Shea Director
    Buy
    $107K 3,750 shares at $28.46 New stake
    Traded Dec 4–5 Filed Dec 8, 2025
  6. Edwin B. Moran President
    Buy
    $14K 500 shares at $27.29 +100% to stake
    Traded Nov 24, 2025 Filed Nov 24, 2025

Also filed in the last 12 months, not counted as buying or selling: 3 sales back to the company, 3 option exercises, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
8-K 8.01,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 4.01,9.01
8-K 5.07,8.01,9.01
10-Q
8-K 2.02,9.01
DEF 14A
DEFA14A
8-K 8.01,9.01
10-K
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 8.01,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 8.01,9.01
10-Q
8-K 2.02,9.01
8-K 5.07
8-K 8.01,9.01
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.